252 related articles for article (PubMed ID: 16954386)
1. Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.
Laricchia-Robbio L; Fazzina R; Li D; Rinaldi CR; Sinha KK; Chakraborty S; Nucifora G
Mol Cell Biol; 2006 Oct; 26(20):7658-66. PubMed ID: 16954386
[TBL] [Abstract][Full Text] [Related]
2. EVI1 Impairs myelopoiesis by deregulation of PU.1 function.
Laricchia-Robbio L; Premanand K; Rinaldi CR; Nucifora G
Cancer Res; 2009 Feb; 69(4):1633-42. PubMed ID: 19208846
[TBL] [Abstract][Full Text] [Related]
3. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
[TBL] [Abstract][Full Text] [Related]
4. Ski negatively regulates erythroid differentiation through its interaction with GATA1.
Ueki N; Zhang L; Hayman MJ
Mol Cell Biol; 2004 Dec; 24(23):10118-25. PubMed ID: 15542823
[TBL] [Abstract][Full Text] [Related]
5. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
Ohmori S; Takai J; Ishijima Y; Suzuki M; Moriguchi T; Philipsen S; Yamamoto M; Ohneda K
Mol Cell Biol; 2012 Dec; 32(23):4742-55. PubMed ID: 22988301
[TBL] [Abstract][Full Text] [Related]
6. Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome.
Dickstein J; Senyuk V; Premanand K; Laricchia-Robbio L; Xu P; Cattaneo F; Fazzina R; Nucifora G
Proc Natl Acad Sci U S A; 2010 May; 107(21):9783-8. PubMed ID: 20448201
[TBL] [Abstract][Full Text] [Related]
7. Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation.
Li L; Freudenberg J; Cui K; Dale R; Song SH; Dean A; Zhao K; Jothi R; Love PE
Blood; 2013 May; 121(22):4575-85. PubMed ID: 23610375
[TBL] [Abstract][Full Text] [Related]
8. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.
Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G
Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925
[TBL] [Abstract][Full Text] [Related]
9. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
[TBL] [Abstract][Full Text] [Related]
10. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
[TBL] [Abstract][Full Text] [Related]
11. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.
Leonards K; Almosailleakh M; Tauchmann S; Bagger FO; Thirant C; Juge S; Bock T; Méreau H; Bezerra MF; Tzankov A; Ivanek R; Losson R; Peters AHFM; Mercher T; Schwaller J
Nat Commun; 2020 Jun; 11(1):2807. PubMed ID: 32533074
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
Freson K; Thys C; Wittewrongel C; Vermylen J; Hoylaerts MF; Van Geet C
Hum Genet; 2003 Jan; 112(1):42-9. PubMed ID: 12483298
[TBL] [Abstract][Full Text] [Related]
13. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
[TBL] [Abstract][Full Text] [Related]
15. Analysis of disease-causing GATA1 mutations in murine gene complementation systems.
Campbell AE; Wilkinson-White L; Mackay JP; Matthews JM; Blobel GA
Blood; 2013 Jun; 121(26):5218-27. PubMed ID: 23704091
[TBL] [Abstract][Full Text] [Related]
16. Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice.
Louz D; van den Broek M; Verbakel S; Vankan Y; van Lom K; Joosten M; Meijer D; Löwenberg B; Delwel R
Leukemia; 2000 Nov; 14(11):1876-84. PubMed ID: 11069022
[TBL] [Abstract][Full Text] [Related]
17. Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.
Chlon TM; McNulty M; Goldenson B; Rosinski A; Crispino JD
Haematologica; 2015 May; 100(5):575-84. PubMed ID: 25682601
[TBL] [Abstract][Full Text] [Related]
18. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.
Zhang P; Zhang X; Iwama A; Yu C; Smith KA; Mueller BU; Narravula S; Torbett BE; Orkin SH; Tenen DG
Blood; 2000 Oct; 96(8):2641-8. PubMed ID: 11023493
[TBL] [Abstract][Full Text] [Related]
19. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation.
Suzuki M; Kobayashi-Osaki M; Tsutsumi S; Pan X; Ohmori S; Takai J; Moriguchi T; Ohneda O; Ohneda K; Shimizu R; Kanki Y; Kodama T; Aburatani H; Yamamoto M
Genes Cells; 2013 Nov; 18(11):921-33. PubMed ID: 23911012
[TBL] [Abstract][Full Text] [Related]
20. Regulation of GATA1 levels in erythropoiesis.
Gutiérrez L; Caballero N; Fernández-Calleja L; Karkoulia E; Strouboulis J
IUBMB Life; 2020 Jan; 72(1):89-105. PubMed ID: 31769197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
